These data support the further investigation of Aβ-induced membrane damage as an etiological mechanism of DN formation and AD pathogenesis, and the potential therapeutic use of annexin A6 to mediate membrane repair that would disrupt the link between Aβ and tau pathologies for the prevention of AD. Here, MAPT is linked to Alzheimer disease.